<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="35619">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02642861</url>
  </required_header>
  <id_info>
    <org_study_id>Muscle cramps treatment</org_study_id>
    <nct_id>NCT02642861</nct_id>
  </id_info>
  <brief_title>Cyclobenzaprine in Muscle Cramps With Liver Cirrhosis</brief_title>
  <official_title>Cyclobenzaprine Treatment for Muscle Cramps in Cirrhotic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tanta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tanta University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although a number of mechanisms for cramps in liver disease have been postulated and have
      been targeted by medical therapies, a clear picture of the causal events has not emerged.
      Several agents as vitamin E, human albumin, zinc, taurine, eperisone hydrochloride and
      branched-chain amino acids have shown some benefit in small uncontrolled studies, although
      large randomized controlled trials are lacking.

      - Cyclobenzaprine, is a muscle relaxer medication used to relieve skeletal muscle spasms. It
      is one of the best-studied drug for this application.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Although a number of mechanisms for cramps in liver disease have been postulated and have
      been targeted by medical therapies, a clear picture of the causal events has not emerged.
      Several agents as vitamin E, human albumin, zinc, taurine, eperisone hydrochloride and
      branched-chain amino acids have shown some benefit in small uncontrolled studies, although
      large randomized controlled trials are lacking.

      - Cyclobenzaprine, is a muscle relaxer medication used to relieve skeletal muscle spasms. It
      is one of the best-studied drug for this application.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of muscle cramps</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Liver Cirrhosis</condition>
  <arm_group>
    <arm_group_label>Cyclobenzaprine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cyclobenzaprine administration for 2 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PLacebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Calcium carbonate for 2 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cyclobenzaprine</intervention_name>
    <description>cyclobenzaprine administration for 2 weeks</description>
    <arm_group_label>Cyclobenzaprine</arm_group_label>
    <other_name>cyclosed</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Calcium Carbonate</intervention_name>
    <description>Calcium carbonate for 2 weeks</description>
    <arm_group_label>PLacebo</arm_group_label>
    <other_name>Calcitron</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Liver cirrhosis and has frequent muscle cramps

        Exclusion Criteria:

          -  Allergy to cyclobenzaprine

          -  Encephalopathy.

          -  Receiving antidepressant drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sherief M. Abd-Elsalam, Consultant</last_name>
    <role>Principal Investigator</role>
    <affiliation>liver diseases dept.- Tanta university hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Walaa A. Elkhalawany, Consultant</last_name>
    <role>Study Director</role>
    <affiliation>liver diseases dept.- Tanta university hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sherief M. Abd-Elsalam, Consultant</last_name>
    <phone>00201095159522</phone>
    <email>sherif_tropical@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tanta university - faculty of medicine</name>
      <address>
        <city>Tanta</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>October 17, 2016</lastchanged_date>
  <firstreceived_date>December 25, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tanta University</investigator_affiliation>
    <investigator_full_name>Sherief Abd-Elsalam</investigator_full_name>
    <investigator_title>Consultant liver and GIT diseases- Tanta university hospital</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Muscle Cramp</mesh_term>
    <mesh_term>Spasm</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Calcium, Dietary</mesh_term>
    <mesh_term>Calcium Carbonate</mesh_term>
    <mesh_term>Cyclobenzaprine</mesh_term>
    <mesh_term>Amitriptyline</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
